Zika: Response funding

July 2016 to December 2017

Updated 31 January 2017

WHO/PAHO and partners have set out a strategic response to Zika that focuses on preventing and managing medical complications caused by Zika virus infection. To date, US$112.5 million are necessary to effectively implement the Zika Strategic Response Plan, October 2016 to December 2017. WHO's funding need until December 2017 stands at US$ 19 million.

5 reasons to support WHO’s global response to Zika virus

  • WHO is the only agency with universal legitimacy in matters of international health, to lead and coordinate the response to Zika.
  • WHO helps countries develop and strengthen health and social services for individuals, families and communities affected by Zika.
  • WHO fast-tracks the availability of effective diagnostic tests, vaccines and public health guidance.
  • WHO works with countries to prevent adverse health outcomes through mosquito control, risk communication and community engagement.
  • WHO communicates vital information to decision-makers.

Zika virus and its complications, such as microcephaly and Guillain-Barré syndrome, represent a new type of public health threat with long-term consequences for families, communities and countries. As the Zika response moves from an acute emergency setting to a longer-term programmatic approach, funding must also transition to longer-term national and international development and technical assistance programmes.

Between February 2016 and January 2017 WHO/PAHO received 24.9 US$ million in direct contributions from 13 donors. This support has been pivotal in enabling a rapid and effective response. Priority areas for funding from October 2016 to December 2017 include investment in research and development for better scientific understanding of Zika virus epidemiology, prevention of adverse health outcomes associated with Zika virus infection through integrated vector management, risk communication and community engagement, and support for health systems in order to provide appropriate guidance on effective guidance on effective surveillance and management of Zika in countries with high vulnerability and low capacity.

In addition to the above contributions, the amount of US$3.8 million has been allocated to the Zika response from the WHO Contingency Fund for Emergencies. This amount will need to be reimbursed to the Contingency Fund for future emergencies.

Report to donors

WHO looks back on its key activities for the Zika response, as it refocuses priorities for the long-term management of the disease.

This page links all WHO information to its response on the Public Health Emergency of International Concern